13F HOLDINGS REPORT
ACORN CAPITAL ADVISORS, LLC
Quarter ended Q3 2025 · Filed November 17, 2025 · Accession 0001636587-25-000060
Total Value
$197.0M
Positions
20
Other Managers
0
Confidential Omitted
No
Holdings (20)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CG ONCOLOGY INC | CGON | 1,131,501 | $45.6M | 23.14% |
| 2 | UROGEN PHARMA LTD | URGN | 1,259,749 | $25.1M | 12.76% |
| 3 | PUMA BIOTECHNOLOGY INC | PBYI | 4,131,299 | $21.9M | 11.14% |
| 4 | TREVI THERAPEUTICS INC | TRVI | 2,144,844 | $19.6M | 9.96% |
| 5 | TERNS PHARMACEUTICALS INC | TERN | 1,971,264 | $14.8M | 7.52% |
| 6 | CANDEL THERAPEUTICS INC | CADL | 2,580,517 | $13.2M | 6.68% |
| 7 | BICARA THERAPEUTICS | BCAX | 643,382 | $10.2M | 5.16% |
| 8 | ONKURE THERAPEUTICS INC | OKUR | 2,839,674 | $7.8M | 3.96% |
| 9 | PROTARA THERAPEUTICS INC | TARA | 1,752,115 | $7.6M | 3.87% |
| 10 | VERASTEM INC | VSTM | 779,498 | $6.9M | 3.49% |
| 11 | CYBIN INC | HELP | 734,394 | $4.3M | 2.19% |
| 12 | CARDIF ONCOLOGY INC | CRDF | 1,962,084 | $4.0M | 2.05% |
| 13 | AURA BIOSCIENCES INC | AURA | 595,744 | $3.7M | 1.87% |
| 14 | BIOATLA INC | BCAB | 4,835,111 | $3.3M | 1.69% |
| 15 | JASPER THERAPEUTICS | JSPRW | 1,382,640 | $3.3M | 1.67% |
| 16 | WHITEHAWK THERAPEUTICS INC | WHWK | 1,139,363 | $2.2M | 1.10% |
| 17 | Q32 BIO INC. | QTTB | 803,425 | $1.6M | 0.81% |
| 18 | X4 PHARMACEUTICALS INC | XFOR | 273,349 | $934,855 | 0.47% |
| 19 | ACRIVON THERAPEUTICS INC | ACRV | 405,237 | $733,479 | 0.37% |
| 20 | VYNE THERAPEUTICS INC | VYNE | 586,572 | $199,434 | 0.10% |